{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,25]],"date-time":"2026-08-25T05:18:44Z","timestamp":1787635124964,"version":"build-2736575974"},"reference-count":26,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,8,25]],"date-time":"2026-08-25T00:00:00Z","timestamp":1787616000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Endocrinol."],"abstract":"<jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Type 2 diabetes mellitus (T2DM) is increasingly recognized as a heterogeneous metabolic disorder characterized by varying contributions of insulin resistance and pancreatic \u03b2-cell dysfunction. However, data on early metabolic phenotypes at diagnosis remain limited in Central Asian populations.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>In this cross-sectional study, 240 adults with newly diagnosed T2DM were recruited from primary health care facilities in the Aktobe region of Kazakhstan between May 2024 and January 2025. Islet autoantibodies (GAD, IA-2, ZnT8, and ICA) were measured to exclude autoimmune diabetes. After exclusion of seropositive individuals, 178 autoantibody-negative participants were analyzed. Insulin resistance and \u03b2-cell function were assessed using the HOMA2 model, and metabolic phenotypes were explored using unsupervised clustering based on BMI, HbA1c, HOMA2-IR, HOMA2-%B, and basal C-peptide.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Among the 178 autoantibody-negative individuals, insulin resistance defined as HOMA2-IR \u22651.6 was observed in 59% of participants, whereas \u03b2-cell dysfunction defined as basal C-peptide &amp;lt;1.70 ng\/mL was present in 30.9%. Unsupervised clustering identified four distinct metabolic phenotypes. Cluster 1 represented the largest subgroup (42.1%) and demonstrated a relatively balanced metabolic profile. Cluster 2 (12.9%) was characterized by obesity-associated hyperinsulinemia with elevated BMI and C-peptide levels. Cluster 3 (25.3%) showed marked hyperglycemia accompanied by reduced \u03b2-cell function, whereas Cluster 4 (19.7%) combined increased BMI with relatively preserved \u03b2-cell function and lower glycemic burden.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Newly diagnosed T2DM in the Kazakh population demonstrates substantial metabolic heterogeneity already at the time of diagnosis. Identification of distinct metabolic phenotypes using routinely available clinical variables may provide a framework for future studies evaluating precision-based approaches to diabetes management.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fendo.2026.1824856","type":"journal-article","created":{"date-parts":[[2026,8,25]],"date-time":"2026-08-25T04:23:31Z","timestamp":1787631811000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["Metabolic heterogeneity at the onset of type 2 diabetes: phenotypes of insulin resistance and \u03b2-cell function in the Kazakh population"],"prefix":"10.3389","volume":"17","author":[{"given":"Bibigul","family":"Tleumagambetova","sequence":"first","affiliation":[{"name":"Department of Internal Diseases No 1, West Kazakhstan Marat Ospanov Medical University","place":["Aktobe, Kazakhstan"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raikul","family":"Kosmuratova","sequence":"additional","affiliation":[{"name":"Department of Internal Diseases No 1, West Kazakhstan Marat Ospanov Medical University","place":["Aktobe, Kazakhstan"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Khatimya","family":"Kudabayeva","sequence":"additional","affiliation":[{"name":"Department of Internal Diseases No 1, West Kazakhstan Marat Ospanov Medical University","place":["Aktobe, Kazakhstan"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yerlan","family":"Bazargaliyev","sequence":"additional","affiliation":[{"name":"Department of Internal Diseases No 1, West Kazakhstan Marat Ospanov Medical University","place":["Aktobe, Kazakhstan"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,8,25]]},"reference":[{"key":"B1","article-title":"IDF Diabetes Atlas","year":"2025"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.21203\/RS.3.RS-7806402\/V1","article-title":"The economic burden of diabetes mellitus in Kazakhstan: systemic gaps, prescription inefficiencies, and policy solutions for sustainable healthcare","author":"Akanov","year":"2025"},{"key":"B3","doi-asserted-by":"publisher","first-page":"965","DOI":"10.1007\/S12020-024-03772-W","article-title":"Early onset type 2 diabetes mellitus: an update","volume":"85","author":"Strati","year":"2024","journal-title":"Endocrine"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1210\/ENDREV\/BNAB021","article-title":"The \u03b2 cell in diabetes: integrating biomarkers with functional measures","volume":"42","author":"Kahn","year":"2021","journal-title":"Endocr Rev"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.3803\/EnM.2016.31.3.354","article-title":"Insulin secretory capacity and insulin resistance in Korean type 2 diabetes mellitus patients","volume":"31","author":"Kim","year":"2016","journal-title":"Endocrinol Metab (Seoul Korea)"},{"key":"B6","doi-asserted-by":"publisher","first-page":"641","DOI":"10.4093\/DMJ.2021.0220","article-title":"Assessment of insulin secretion and insulin resistance in human","volume":"45","author":"Park","year":"2021","journal-title":"Diabetes Metab J"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1136\/bmjdrc-2022-002909","article-title":"Comprehensive validation of fasting-based and oral glucose tolerance test-based indices of insulin secretion against gold standard measures","volume":"10","author":"Prystupa","year":"2022","journal-title":"BMJ Open Diabetes Res Care"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1007\/BF00280883","article-title":"Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man","volume":"28","author":"Matthews","year":"1985","journal-title":"Diabetologia"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.2337\/DIACARE.27.6.1487","article-title":"Use and abuse of HOMA modeling","volume":"27","author":"Wallace","year":"2004","journal-title":"Diabetes Care"},{"key":"B10","doi-asserted-by":"publisher","first-page":"32081","DOI":"10.1038\/s41598-024-83817-2","article-title":"Association between HOMA2 based beta-cell function or insulin resistance and long-term outcomes in kidney transplant recipients with type 2 diabetes","volume":"141","author":"Maanaoui","year":"2024","journal-title":"Sci Rep"},{"key":"B11","article-title":"\"Anthropometric Measurement.\"","author":"Casadei","year":"2022","journal-title":"StatPearls"},{"key":"B12","article-title":"Obesity : preventing and managing the global epidemic : report of a WHO consultation","year":"2000"},{"key":"B13","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1007\/s42000-025-00701-y","article-title":"Diabetes mellitus as a multisystem disease: understanding subtypes, complications, and the link with steatotic liver diseases in humans","volume":"25","author":"Giannakogeorgou","year":"2026","journal-title":"Hormones (Athens)"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.2337\/DBI20-0001","article-title":"Subtypes of type 2 diabetes determined from clinical parameters","volume":"69","author":"Ahlqvist","year":"2020","journal-title":"Diabetes"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1111\/OBR.13393","article-title":"Sex differences in regional adipose tissue depots pose different threats for the development of type 2 diabetes in males and females","volume":"23","author":"Delaney","year":"2022","journal-title":"Obes Rev"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.2337\/dc21-0429","article-title":"Increased risk of incident heart failure and death is associated with insulin resistance in people with newly diagnosed type 2 diabetes: UKPDS 89","volume":"44","author":"Wamil","year":"2021","journal-title":"Diabetes Care"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1016\/S2213-8587(18)30051-2","article-title":"Novel subgroups of adult-onset diabetes and their association with outcomes: a data-driven cluster analysis of six variables","volume":"6","author":"Ahlqvist","year":"2018","journal-title":"Lancet Diabetes Endocrinol"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1016\/J.DIABRES.2024.111872","article-title":"Identifying subtypes of type 2 diabetes mellitus based on real-world electronic medical record data in China","volume":"217","author":"Wang","year":"2024","journal-title":"Diabetes Res Clin Pract"},{"key":"B19","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1016\/S2213-8587(18)30316-4","article-title":"Novel subgroups of patients with adult-onset diabetes in Chinese and US populations","volume":"7","author":"Zou","year":"2019","journal-title":"Lancet Diabetes Endocrinol"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2021.617628","article-title":"Clinical characteristics and risk of diabetic complications in data-driven clusters among type 2 diabetes","volume":"12","author":"Xing","year":"2021","journal-title":"Front Endocrinol (Lausanne)"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.2337\/db25-0871","article-title":"Cluster analysis of younger-onset type 2 diabetes in an Asian cohort reveals distinct subgroups with differential pathophysiology and outcomes","volume":"75","author":"Tan","year":"2026","journal-title":"Diabetes"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1016\/J.DSX.2023.102936","article-title":"Secondary analysis of newly diagnosed type 2 diabetes subgroups and treatment responses in the MARCH cohort","volume":"18","author":"Wang","year":"2024","journal-title":"Diabetes Metab Syndr Clin Res Rev"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1016\/J.DSX.2024.102993","article-title":"Phenotypic clusters of type 2 diabetes mellitus among North Indians reveal higher levels of insulin deficiency along with insulin resistance","volume":"18","author":"Arora","year":"2024","journal-title":"Diabetes Metab Syndr Clin Res Rev"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1111\/DOM.14063","article-title":"Validation of distinct type 2 diabetes clusters and their association with diabetes complications in the DEVOTE, LEADER and SUSTAIN-6 cardiovascular outcomes trials","volume":"22","author":"Kahkoska","year":"2020","journal-title":"Diabetes Obes Metab"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1016\/J.CELL.2024.06.029","article-title":"Diabetes mellitus\u2014progress and opportunities in the evolving epidemic","volume":"187","author":"Abel","year":"2024","journal-title":"Cell"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.3390\/medicina61071247","article-title":"Maresin 1 and CHI3L1 levels exhibit opposing trends and correlations with renal dysfunction in diabetic nephropathy","volume":"61","author":"Bulu","year":"2025","journal-title":"Med (Kaunas)"}],"container-title":["Frontiers in Endocrinology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fendo.2026.1824856\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,25]],"date-time":"2026-08-25T04:23:32Z","timestamp":1787631812000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fendo.2026.1824856\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,25]]},"references-count":26,"alternative-id":["10.3389\/fendo.2026.1824856"],"URL":"https:\/\/doi.org\/10.3389\/fendo.2026.1824856","relation":{},"ISSN":["1664-2392"],"issn-type":[{"value":"1664-2392","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,25]]},"article-number":"1824856"}}